These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 7696114)
1. The effect of erythropoietin on platelet function in uraemic children on haemodialysis. Turi S; Soos J; Torday C; Bereczki C; Havass Z Pediatr Nephrol; 1994 Dec; 8(6):727-32. PubMed ID: 7696114 [TBL] [Abstract][Full Text] [Related]
2. The effects of bicarbonate and acetate haemodialysis on platelet cyclic AMP concentration, thromboxane B2 release and aggregation. Túri S; Bereczki C; Torday C; Havass Z; Németh M Pediatr Nephrol; 1991 May; 5(3):327-31. PubMed ID: 1651098 [TBL] [Abstract][Full Text] [Related]
3. Effect of human recombinant erythropoietin on bleeding time, platelet number and function in children with end-stage renal disease maintained by haemodialysis. Fabris F; Cordiano I; Randi ML; Casonato A; Montini G; Zacchello G; Girolami A Pediatr Nephrol; 1991 Mar; 5(2):225-8. PubMed ID: 2031840 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of erythropoietin on platelet serotonin storage and platelet aggregation in hemodialysis patients with reference to ketanserin treatment. Borawski J; Rydzewski A; Pawlak K; Azzadin A; Buczko W; Mysliwiec M Thromb Res; 1998 May; 90(4):171-80. PubMed ID: 9692616 [TBL] [Abstract][Full Text] [Related]
5. Laser aggregometer studies, ATP release and thromboxane B2 release and cAMP concentration of the platelets in nephrotic syndrome. Turi S; Bereczki C; Torday C; Havass Z Prostaglandins Leukot Essent Fatty Acids; 1994 Jul; 51(1):69-73. PubMed ID: 7938102 [TBL] [Abstract][Full Text] [Related]
6. Inverse relationships between haemoglobin and ristocetin-induced platelet aggregation in haemodialysis patients under erythropoietin therapy. Borawski J; Rydzewski A; Mazerska M; Kalinowski M; Pawlak K; Mysliwiec M Nephrol Dial Transplant; 1996 Dec; 11(12):2444-8. PubMed ID: 9017620 [TBL] [Abstract][Full Text] [Related]
7. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis. Bloom A; Greaves M; Preston FE; Brown CB Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018 [TBL] [Abstract][Full Text] [Related]
8. Recombinant human erythropoietin increases blood pressure, platelet aggregability and platelet free calcium mobilisation in uraemic children: a possible link? Van Geet C; Van Damme-Lombaerts R; Vanrusselt M; de Mol A; Proesmans W; Vermylen J Thromb Haemost; 1990 Aug; 64(1):7-10. PubMed ID: 2274929 [TBL] [Abstract][Full Text] [Related]
9. Defective calcium signalling in uraemic platelets and its amelioration with long-term erythropoietin therapy. Zhou XJ; Vaziri ND Nephrol Dial Transplant; 2002 Jun; 17(6):992-7. PubMed ID: 12032187 [TBL] [Abstract][Full Text] [Related]
10. Platelet aggregation in erythropoietin treated dialysis patients. Taylor JE; Henderson IS; Stewart WK; Belch JJ Platelets; 1992; 3(1):47-52. PubMed ID: 21043900 [TBL] [Abstract][Full Text] [Related]
11. Low haematocrit and prolonged bleeding time in uraemic patients: effect of red cell transfusions. Fernandez F; Goudable C; Sie P; Ton-That H; Durand D; Suc JM; Boneu B Br J Haematol; 1985 Jan; 59(1):139-48. PubMed ID: 3918557 [TBL] [Abstract][Full Text] [Related]
12. [The effect of human recombinant erythropoietin on distribution of membrane phospholipids in blood platelets of patients with uremia treated with repeated hemodialysis]. Krawczyk W; Ledwozyw A; Dmoszyńska A; Krzywicka A; Rózyc P Pol Arch Med Wewn; 1997 Feb; 97(2):120-5. PubMed ID: 9312760 [TBL] [Abstract][Full Text] [Related]
13. Expression of fibrinogen receptors and GPIIb molecules on uraemic platelets: effect of recombinant human erythropoietin therapy. Krzesłowska J; Rysz J; Cierniewski CS; Luciak M Nephrol Dial Transplant; 1995; 10(5):653-6. PubMed ID: 7566578 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin shortens the uraemic bleeding time without causing intravascular haemostatic activation. Gordge MP; Leaker B; Patel A; Oviasu E; Cameron JS; Neild GH Thromb Res; 1990 Jan; 57(2):171-82. PubMed ID: 2315882 [TBL] [Abstract][Full Text] [Related]
15. [Effect of erythropoietin therapy on alpha receptor density in chronic dialysis patients]. Fritschka E; Neumayer HH; Seddighi S; Distler A; Philipp T Med Klin (Munich); 1991 Jul; 86(7):353-9. PubMed ID: 1656181 [TBL] [Abstract][Full Text] [Related]
16. [Platelet aggregation during the recombinant human erythropoietin (rHuEPO) treatment of patients with uremia]. Mazerska M; Pawlak K; Azzadin A; Małyszko J; Małyszko J; Myśliwiec M; Buczko W Pol Arch Med Wewn; 1992 Oct; 88(4):230-7. PubMed ID: 1488323 [TBL] [Abstract][Full Text] [Related]
17. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production. Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062 [TBL] [Abstract][Full Text] [Related]
18. [Influence of long-term treatment with human recombinant erythropoietin on secretion of hormones regulating carbohydrate metabolism in hemodialyzed patients with chronic uremia]. Nieszporek T; Kokot F; Wiecek A; Marcinkowski W; Rudka R; Trembecki J Pol Arch Med Wewn; 1995 Dec; 94(6):488-94. PubMed ID: 8618811 [TBL] [Abstract][Full Text] [Related]
19. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis. Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of thromboxane B2 in uraemia and the effects of dialysis. Winter M; Frampton G; Bennett A; Machin SJ; Cameron JS Thromb Res; 1983 May; 30(3):265-72. PubMed ID: 6868024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]